“We’re additionally working onerous to fulfil the steps essential to restart manufacturing of Similac and different formulation,” Abbott stated, referring to its extra mainstream merchandise. It plans to ramp up manufacturing as shortly as potential “whereas assembly all necessities”, it stated.